PubRank

Carlo C Maley

Author PubWeight™ 61.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clonal evolution in cancer. Nature 2012 11.07
2 Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006 9.33
3 Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 2007 3.00
4 Peto's Paradox: evolution's prescription for cancer prevention. Trends Ecol Evol 2011 2.48
5 Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res 2006 2.24
6 NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med 2007 2.23
7 A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Phila) 2010 1.89
8 Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays 2014 1.64
9 Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila) 2008 1.43
10 Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS One 2011 1.32
11 Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) 2013 1.31
12 Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res (Phila) 2011 1.21
13 Animal cell differentiation patterns suppress somatic evolution. PLoS Comput Biol 2007 1.19
14 Cancer in light of experimental evolution. Curr Biol 2012 1.17
15 Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 2009 1.17
16 Life history trade-offs in cancer evolution. Nat Rev Cancer 2013 1.16
17 Solving the puzzle of metastasis: the evolution of cell migration in neoplasms. PLoS One 2011 1.12
18 The role of genetic diversity in cancer. J Clin Invest 2010 1.05
19 Modelling the evolution of genetic instability during tumour progression. Evol Appl 2012 1.04
20 Spatial structure increases the waiting time for cancer. New J Phys 2011 1.02
21 NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet 2013 0.98
22 Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Cancer Epidemiol Biomarkers Prev 2006 0.98
23 Preneoplastic lesion growth driven by the death of adjacent normal stem cells. Proc Natl Acad Sci U S A 2008 0.97
24 New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management. Clin Cancer Res 2011 0.96
25 NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biol Blood Marrow Transplant 2010 0.95
26 Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prev Res (Phila) 2011 0.91
27 Deletion at fragile sites is a common and early event in Barrett's esophagus. Mol Cancer Res 2010 0.89
28 Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev 2006 0.87
29 Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox. BMC Cancer 2012 0.87
30 Sequence space coverage, entropy of genomes and the potential to detect non-human DNA in human samples. BMC Genomics 2008 0.87
31 Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms. Arch Pathol Lab Med 2010 0.84
32 An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition. BMC Cancer 2011 0.83
33 An evolutionary explanation for the presence of cancer nonstem cells in neoplasms. Evol Appl 2012 0.82
34 New models of neoplastic progression in Barrett's oesophagus. Biochem Soc Trans 2010 0.80
35 Development and characterization of an organotypic model of Barrett's esophagus. J Cell Physiol 2012 0.80
36 Polyploidy, aneuploidy and the evolution of cancer. Adv Exp Med Biol 2010 0.78
37 Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol 2005 0.78